Mepolizumab for the treatment of severe eosinophilic asthma. Rev Alerg Mex [Internet]. 2021 Jan. 13 [cited 2026 Sep. 23];67(7). Available from: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/780